Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548236 · ClinicalTrials.gov registry record · NA
The Active After Cancer Trial (AACT)
A NA study of Breast Cancer and Colorectal Cancer, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 9
- Study locations
NCT00548236 is a NA study of Breast Cancer and Colorectal Cancer that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 120 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 9 study locations across 6 states.
The verdict
NCT00548236, a NA study of Breast Cancer and Colorectal Cancer, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 9
- Study locations
Study Summary
This study is being done to determine whether a telephone-based counseling intervention can help survivors of breast and colorectal cancer increase their weekly physical activity. Observational evidence suggests that physical activity after breast and colorectal cancer diagnosis decreases recurrence rates. Unfortunately, many people become less active during cancer therapy, and a substantial proportion never return to pre-diagnosis levels of physical activity. This study looks to see if people who have recently finished chemotherapy for breast, colon or rectal cancer can be motivated to increase their exercise by talking to an exercise specialist over the phone. The study also looks at changes in mood, fatigue, fitness, fat distribution and weight.
Conditions Studied
Interventions
- BEHAVIORAL Telephone-Based exercise intervention
Study Locations (9)
California
- University of California at San Diego - La Jolla
- University of California San Francisco - San Francisco
New Hampshire
- New Hampshire Oncology Hematology - Concord
- Lakes Regional Healthcare Hematology Oncology - Hooksett
New York
- Rosewell Park Cancer Institute - Buffalo
- Hematology Oncology Associates of Central New York - East Syracuse
Massachusetts
- Dana-Farber Cancer Institute - Boston
Ohio
- Ohio State University - Columbus
Vermont
- Vermont Cancer Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2007-10 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00548236
The ClinicalTrials.gov registry entry for NCT00548236 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Telephone-Based exercise intervention is the first listed.
NCT00548236 reports 9 study locations spanning 6 distinct geographic areas - top geographies include California, New Hampshire, New York.
Frequently Asked Questions
What is clinical trial NCT00548236 about?
NCT00548236 is a clinical study titled "The Active After Cancer Trial (AACT)". This study is being done to determine whether a telephone-based counseling intervention can help survivors of breast and colorectal cancer increase their weekly physical activity. Observational evidence suggests that physical activity after breast and colorectal cancer diagnosis decreases recurrence...
What is the current status of trial NCT00548236?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2007-10. Estimated completion is 2026-12.
What conditions does trial NCT00548236 study?
This clinical trial studies the following conditions: Breast Cancer, Colorectal Cancer.
What interventions are being tested in trial NCT00548236?
The interventions under investigation include: Telephone-Based exercise intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00548236?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00548236 being conducted?
This trial has 9 study locations across California, Massachusetts, New Hampshire, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.